Flavia Raggi

755 total citations
12 papers, 144 citations indexed

About

Flavia Raggi is a scholar working on Genetics, Immunology and Molecular Biology. According to data from OpenAlex, Flavia Raggi has authored 12 papers receiving a total of 144 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 8 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in Flavia Raggi's work include Chronic Lymphocytic Leukemia Research (8 papers), Galectins and Cancer Biology (3 papers) and Acute Lymphoblastic Leukemia research (2 papers). Flavia Raggi is often cited by papers focused on Chronic Lymphocytic Leukemia Research (8 papers), Galectins and Cancer Biology (3 papers) and Acute Lymphoblastic Leukemia research (2 papers). Flavia Raggi collaborates with scholars based in Italy, Denmark and United States. Flavia Raggi's co-authors include Andrea Visentin, Valentina Trimarco, Livio Trentin, Federica Frezzato, Veronica Martini, Filippo Severin, Monica Facco, Gianpietro Semenzato, Francesco Piazza and Silvia Imbergamo and has published in prestigious journals such as Blood, International Journal of Cancer and Cellular and Molecular Life Sciences.

In The Last Decade

Flavia Raggi

11 papers receiving 144 citations

Peers

Flavia Raggi
Alicia Steffens United States
Sujuan Jia United States
Mariko Nakano‐Okuno United States
Katharine Chen United States
Rena Zheng United States
Flavia Raggi
Citations per year, relative to Flavia Raggi Flavia Raggi (= 1×) peers Andrés Caballero-Oteyza

Countries citing papers authored by Flavia Raggi

Since Specialization
Citations

This map shows the geographic impact of Flavia Raggi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Flavia Raggi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Flavia Raggi more than expected).

Fields of papers citing papers by Flavia Raggi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Flavia Raggi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Flavia Raggi. The network helps show where Flavia Raggi may publish in the future.

Co-authorship network of co-authors of Flavia Raggi

This figure shows the co-authorship network connecting the top 25 collaborators of Flavia Raggi. A scholar is included among the top collaborators of Flavia Raggi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Flavia Raggi. Flavia Raggi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Raggi, Flavia, Susanna Ruggero, Mara Seguso, et al.. (2021). Evaluation of peripherin in biofluids of patients with motor neuron diseases. Annals of Clinical and Translational Neurology. 8(8). 1750–1754. 15 indexed citations
2.
Fabbrizio, Paola, Nicolò Panini, Laura Pasetto, et al.. (2021). Contingent intramuscular boosting of P2XR7 axis improves motor function in transgenic ALS mice. Cellular and Molecular Life Sciences. 79(1). 7–7. 7 indexed citations
3.
Meneghetti, Giacomo, Tatjana Skobo, Martina Chrisam, et al.. (2019). The epg5 knockout zebrafish line: a model to study Vici syndrome. Autophagy. 15(8). 1438–1454. 16 indexed citations
4.
Visentin, Andrea, Monica Facco, Carmela Gurrieri, et al.. (2019). Prognostic and Predictive Effect of IGHV Mutational Status and Load in Chronic Lymphocytic Leukemia: Focus on FCR and BR Treatments. Clinical Lymphoma Myeloma & Leukemia. 19(10). 678–685.e4. 22 indexed citations
5.
Frezzato, Federica, Flavia Raggi, Veronica Martini, et al.. (2019). HSP70/HSF1 axis, regulated via a PI3K/AKT pathway, is a druggable target in chronic lymphocytic leukemia. International Journal of Cancer. 145(11). 3089–3100. 31 indexed citations
6.
Martini, Veronica, Federica Frezzato, Filippo Severin, et al.. (2018). Abnormal regulation of BCR signalling by c-Cbl in chronic lymphocytic leukaemia. Oncotarget. 9(63). 32219–32231. 7 indexed citations
7.
Severin, Filippo, Federica Frezzato, Veronica Martini, et al.. (2018). Three Different Jak2/Stat3-Related Pathways Favor the Survival of Chronic Lymphocytic Leukemia Neoplastic Clone. Blood. 132(Supplement 1). 4405–4405. 1 indexed citations
8.
Visentin, Andrea, Francesca Romana Mauro, Silvia Imbergamo, et al.. (2018). Protective Role Immunoglobulin Replacement Therapy in Chronic Lymphocytic Leukemia: FOCUS on Subcutaneous Immunoglobulin Formulations. Blood. 132(Supplement 1). 4954–4954. 2 indexed citations
9.
Martini, Veronica, Cristina Gattazzo, Federica Frezzato, et al.. (2017). Cortactin, a Lyn substrate, is a checkpoint molecule at the intersection of BCR and CXCR4 signalling pathway in chronic lymphocytic leukaemia cells. British Journal of Haematology. 178(1). 81–93. 24 indexed citations
10.
Visentin, Andrea, Silvia Imbergamo, Carmela Gurrieri, et al.. (2016). Major infections, secondary cancers and autoimmune diseases occur in different clinical subsets of chronic lymphocytic leukaemia patients. European Journal of Cancer. 72. 103–111. 17 indexed citations
11.
Martini, Veronica, Federica Frezzato, Valentina Trimarco, et al.. (2016). Cortactin Is a New Player in Aggressiveness and Diffusion of Chronic Lymphocytic Leukaemia. Blood. 128(22). 4353–4353.
12.
Severin, Filippo, Federica Frezzato, Veronica Martini, et al.. (2016). Inhibition of JAK2/STAT3 Pathway Leads to Apoptosis in Chronic Lymphocytic Leukemia Cells. Blood. 128(22). 2023–2023. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026